 REHOVOT, Israel and WILMINGTON, Del., Sept. 02, 2021 GLOBE NEWSWIRE -- Ayala Pharmaceuticals, Inc. NASDAQ: AYLA, a clinical-stage oncology company focused on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers, today announced that Ayala management will participate in two upcoming virtual investor conferences in September: 